Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive vs Standard Alteplase Protocol for HD Catheter Dysfunction
NCT02474810Completed
- Sponsor
- Nova Scotia Health
- Start
- Jan 2013
- Primary completion
- Jul 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Open-label trial of tissue-plasminogen activator (2 arms), sponsored by Nova Scotia Health. Primary endpoint: Incident rate of Alteplase use at 9 months. Started Jan 2013; status: completed.
02
Drugs
tissue-plasminogen activator
Beyond the preview
Go deeper on NCT02474810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02474810.